Literature DB >> 28751414

Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment.

Johan Pluvy1,2, Solenn Brosseau1,2, Charles Naltet1,2, Marie-Agnès Opsomer3, Aurélie Cazes4, Claire Danel4, Antoine Khalil5, Gérard Zalcman1,2, Valerie Gounant6,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28751414     DOI： 10.1183/13993003.00310-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Thymus Subset Alterations Accompanying Concomitant Tumor Immunity Mimics Phenotypic Patterns of Cytotoxic Drug Doxorubicin.

Authors:  Gintaras Zaleskis; Dainius Characiejus; Jurgita Jursenaite; Lavija Zibutyte; Karolina Kriauciunaite; Milda Vanagaite-Zickiene; Adas Darinskas; Mantas Jonusis; Vita Pasukoniene
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

Review 2.  Relationship between Patients' Baseline Characteristics and Survival Benefits in Immunotherapy-Treated Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Xuanbo Hu; Yafeng Liu; Yuxiao He; Zibo Wang; Hongyan Zhang; Wei Yang; Jibin Lu
Journal:  J Oncol       Date:  2022-05-19       Impact factor: 4.501

3.  The role of opioids in cancer response to immunotherapy.

Authors:  Andrea Botticelli; Alessio Cirillo; Silvia Mezi; Paolo Marchetti; Giulia Pomati; Bruna Cerbelli; Simone Scagnoli; Michela Roberto; Alain Gelibter; Giulia Mammone; Maria Letizia Calandrella; Edoardo Cerbelli; Francesca Romana Di Pietro; Federica De Galitiis; Gaetano Lanzetta; Enrico Cortesi
Journal:  J Transl Med       Date:  2021-03-23       Impact factor: 5.531

4.  Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Fang Yang; Yucai Wang; Lin Tang; Aaron Scott Mansfield; Alex A Adjei; Konstantinos Leventakos; Narjust Duma; Jia Wei; Lifeng Wang; Baorui Liu; Julian R Molina
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

5.  Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis.

Authors:  Fang Yang; Svetomir N Markovic; Julian R Molina; Thorvardur R Halfdanarson; Lance C Pagliaro; Ashish V Chintakuntlawar; Rutian Li; Jia Wei; Lifeng Wang; Baorui Liu; Grzegorz S Nowakowski; Michael L Wang; Yucai Wang
Journal:  JAMA Netw Open       Date:  2020-08-03

6.  Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients.

Authors:  Valérie Gounant; Michael Duruisseaux; Ghassen Soussi; Sylvie Van Hulst; Olivier Bylicki; Jacques Cadranel; Marie Wislez; Jean Trédaniel; Jean-Philippe Spano; Carole Helissey; Christos Chouaid; Olivier Molinier; Xavier Dhalluin; Ludovic Doucet; José Hureaux; Aurélie Cazes; Gérard Zalcman
Journal:  Cancers (Basel)       Date:  2021-03-02       Impact factor: 6.639

7.  Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.

Authors:  Marco Carlo Merlano; Andrea Abbona; Matteo Paccagnella; Antonella Falletta; Cristina Granetto; Vincenzo Ricci; Elena Fea; Nerina Denaro; Fiorella Ruatta; Anna Merlotti; Oscar Bertetto; Nicola Crosetto; Danilo Galizia; Marco Basiricò; Loretta Gammaitoni; Dario Sangiolo; Massimo Aglietta; Ornella Garrone
Journal:  Vaccines (Basel)       Date:  2021-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.